Table 1.
Rating score and operational definitions of severity of failure, frequency of occurrence, and detection of failure considered to calculate RPN in FMEA in blood bank tests [17].
Table 2.
Comparison between A-XM and M-XM.
Discordant results have shown in bold.
Table 3.
Risk and TAT in each process for A-XM and M-XM.
Table 4.
Comparison of quality and costs between A-XM and M-XM.
Table 5.
Comparison of costs between A-XM and M-XM.
Fig 1.
Suggested pre-transfusion workflow applied to the VISION Max middleware system.
It was based on the comparative analyses and customized rules for the blood bank of Konkuk University Medical Center. Abbreviations: ABS, antibody screening test; DAT, direct antiglobulin test; A-XM, automated cross-matching; M-XM, manual cross-matching.